Obesity
Positive safety data presented for obesity treatment
Published in Obesity and Diabetes Week, June 21st, 2004
In a presentation entitled, "Oleoyl Estrone at Therapeutic Doses: Lack of Endocrine Histopathology in a Two Week, Oral Toxicity Trial in Rats," Manhattan scientists described positive results regarding Oleoyl estrone's safety profile following oral administration to adult rats of both genders. Safety observations were made over a 14 day period, including mortality, gross toxicity, blood, urine and carcass chemistries, blood and urine cellular counts, organ weights and histology.
In groups...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Therapy
Diabetes in older adults reviewed - Diabetes Therapy
Language used in relation to diabetes may undermine therapy efforts - Diet and Nutrition
Arabinogalactan offers no long-term benefits on serum lipids or glucose - Endocrinology
Metabolic products measured by NMR analysis of one glucose derivative - Obesity Pathogenesis
Gastrointestinal satiety signals reviewed - Atherosclerosis
PAD patients should be aggressively treated for atherosclerotic risk factors - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
